Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCA | P17252 | 8/20 | 0.44 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.39 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.39 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22923018 | 0.87 | PRKCA (0.47) | PRKCAPRKCEPRKCQPRKCDCYP1A2 | |
| SCHEMBL30585906 | 0.85 | PRKCA (0.48) | PRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL2266760 | 0.85 | PRKCA (0.48) | PRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL13113020 | 0.80 | PRKCA (0.46) | PRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL2480097 | 0.79 | — | — | |
| SCHEMBL4879570 | 0.79 | PRKCA (0.56) | PRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL10324686 | 0.79 | PRKCA (0.44) | PRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL29102674 | 0.78 | PRKCA (0.42) | PRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL28965206 | 0.78 | PRKCA (0.42) | PRKCAPRKCEPRKCQPRKCD | |
| SCHEMBL22747790 | 0.78 | PRKCA (0.42) | PRKCAPRKCEPRKCQPRKCD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110288230-A1 | METHOD FOR PREPARING POLYHYDROXY-URETHANES | RHODIA OPERATIONS (FR) | 2011-11-24 | — | — | US | disclosed |
| US-8017719-B2 | Method for preparing polyhydroxy-urethanes | RHODIA OPERATIONS (FR) | 2011-09-13 | — | — | US | disclosed |
| CN-101627094-A | Process for preparing polyhydroxy-urethanes | RHODIA OPERATIONS | 2010-01-13 | — | — | CN | disclosed |
| US-20090312502-A1 | Method for preparing polyhydroxy-urethanes | RHODIA OPERATIONS (FR) | 2009-12-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110288230-A1 | METHOD FOR PREPARING POLYHYDROXY-URETHANES | UROD, HPD, ALKBH3 | PRKCA 3061/4885PRKCE 2371/4885PRKCQ 2958/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.